Lipid and lipoprotein metabolism in chronic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Lipidology

Background:

• Declining renal function is associated with increased cardiovascular event risk and mortality.
• Traditional cardiovascular risk factors like Framingham risk factors are altered in kidney disease.
• Lipid metabolism significantly changes in patients with chronic kidney disease (CKD).

Purpose of the Study:

• To investigate the alterations in lipid profiles and their association with cardiovascular risk in patients with declining renal function.
• To understand the mechanisms behind dyslipidemia in chronic kidney disease (CKD) and its impact on cardiovascular outcomes.

Main Methods:

• Analysis of lipid profiles, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, and lipoprotein(a).
• Assessment of lipoprotein particle size, density, and composition.
• Evaluation of lipoprotein metabolism, including synthesis and clearance rates, and enzymatic activities (e.g., lipoprotein lipase, lecithin cholesterol ester transfer protein, paroxonase).

Main Results:

• Low-density lipoprotein (LDL) cholesterol does not predict mortality, but low high-density lipoprotein (HDL) cholesterol and elevated triglycerides remain significant risk factors.
• Lipoprotein particles shift to smaller, denser isoforms; accumulation of apolipoprotein B and lipoprotein(a) is primarily due to decreased clearance.
• HDL in CKD patients exhibits impaired maturation and reduced antioxidative capacity due to decreased lecithin cholesterol ester transfer protein and paroxonase activity, leading to accumulation of oxidized LDL.

Conclusions:

• Dyslipidemia in CKD significantly contributes to cardiovascular risk, with altered HDL function and composition being critical factors.
• Targeting specific lipid abnormalities, beyond LDL cholesterol, may be crucial for managing cardiovascular risk in kidney disease.
• Understanding these lipid alterations provides insights into the complex pathophysiology of cardiovascular disease in CKD.